AI Stock Finder
Loading...
Skip to main content
Model output · Signal date Oct. 15, 2026

Daily SignalsNeutral

2696 companies scored · 2026-10-15 run in progress: 5121 of ~5380 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-15 Cut-offs from the 2026-10-15 run
Companies scored 2696 IC ≥ 0 · market cap ≥ $100M
Median forecast +2.60% Total · 90D
Long–short spread +5.95% Strong Buy minus Strong Sell, mean
Median IC 0.28 Spearman · 90D
Rating changes ▲ 429 ▼ 601 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

49 companies

Sorted by 90D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1 CGENCOMPUGEN LTD Life Sciences 0.42 $189M Neutral +1.01% +3.15% ·
2 OPKOPKO HEALTH, INC. Life Sciences 0.35 $1.2B Neutral +1.09% +3.11% ▼ 1
3 RGENREPLIGEN CORP Life Sciences 0.62 $10.1B Neutral +1.00% +3.08% ▼ 1
4 VCELVericel Corp Life Sciences 0.27 $2.1B Neutral +0.76% +3.08% ·
5 VNDAVanda Pharmaceuticals Inc. Life Sciences 0.39 $255M Neutral +1.08% +3.04% ·
6 KROSKeros Therapeutics, Inc. Life Sciences 0.15 $219M Neutral +1.00% +3.03% ▼ 1
7 ACBAURORA CANNABIS INC Life Sciences 0.17 $264M Neutral +0.93% +2.96% ·
8 RPRXRoyalty Pharma plc Life Sciences 0.59 $33.9B Neutral +0.84% +2.96% ·
9 SABSSAB Biotherapeutics, Inc. Life Sciences 0.14 $227M Neutral +0.96% +2.94% ·
10 SPRBSPRUCE BIOSCIENCES, INC. Life Sciences 0.01 $112M Neutral +1.45% +2.94% ·
11 GMABGENMAB A/S Life Sciences 0.02 $23.7B Neutral +0.98% +2.92% ·
12 AMRXAmneal Pharmaceuticals, Inc. Life Sciences 0.49 $6.0B Neutral +1.01% +2.90% ·
13 HRMYHarmony Biosciences Holdings, Inc. Life Sciences 0.49 $2.2B Neutral +1.03% +2.87% ·
14 NRIXNurix Therapeutics, Inc. Life Sciences 0.26 $2.5B Neutral +0.89% +2.84% ·
15 BBIOBridgeBio Pharma, Inc. Life Sciences 0.07 $12.7B Neutral +0.91% +2.83% ·
16 NBPNovaBridge Biosciences Life Sciences 0.18 $148M Neutral +0.82% +2.82% ·
17 IRWDIRONWOOD PHARMACEUTICALS INC Life Sciences 0.22 $595M Neutral +0.81% +2.80% ▼ 1
18 OMEROMEROS CORP Life Sciences 0.16 $1.3B Neutral +0.80% +2.78% ▼ 1
19 HCMHUTCHMED (China) Ltd Life Sciences 0.12 $2.4B Neutral +0.91% +2.75% ·
20 ANABANAPTYSBIO, INC Life Sciences 0.27 $1.4B Neutral +0.87% +2.69% ·
21 NIKANIKA PHARMACEUTICALS, INC Life Sciences 0.17 $431M Neutral -0.80% +2.67% ·
22 MGTXMeiraGTx Holdings plc Life Sciences 0.30 $904M Neutral +0.75% +2.61% ·
23 SIGASIGA TECHNOLOGIES INC Life Sciences 0.47 $223M Neutral +1.03% +2.60% ·
24 TLRYTilray Brands, Inc. Life Sciences 0.01 $428M Neutral +0.92% +2.60% ·
25 HALOHALOZYME THERAPEUTICS, INC. Life Sciences 0.30 $13.3B Neutral +0.87% +2.58% ·
26 XTLBXTL BIOPHARMACEUTICALS LTD Life Sciences 0.14 $1.9B Neutral +1.10% +2.57% new
27 NAGENiagen Bioscience, Inc. Life Sciences 0.59 $200M Neutral +0.73% +2.54% ·
28 ALNYALNYLAM PHARMACEUTICALS, INC. Life Sciences 0.57 $30.0B Neutral +0.86% +2.52% ▲ 2
29 MSLESatellos Bioscience Inc. Life Sciences 0.36 $102M Neutral +0.88% +2.47% ·
30 VTRSViatris Inc Life Sciences 0.36 $20.0B Neutral +0.76% +2.44% ·
31 RIGLRIGEL PHARMACEUTICALS INC Life Sciences 0.06 $875M Neutral +0.73% +2.40% ▼ 1
32 INSMINSMED Inc Life Sciences 0.42 $21.4B Neutral +0.77% +2.36% ▲ 1
33 NWBONORTHWEST BIOTHERAPEUTICS INC Life Sciences 0.00 $270M Neutral +0.82% +2.36% ·
34 AMRNAMARIN CORP PLC\UK Life Sciences 0.05 $244M Neutral +0.79% +2.34% ·
35 BHCBausch Health Companies Inc. Life Sciences 0.49 $2.2B Neutral +0.67% +2.33% ·
36 MOLNMOLECULAR PARTNERS AG Life Sciences 0.04 $147M Neutral +0.61% +2.29% ·
37 GALTGALECTIN THERAPEUTICS INC Life Sciences 0.07 $367M Neutral +1.05% +2.26% ·
38 QGENQIAGEN N.V. Life Sciences 0.17 $9.9B Neutral +0.71% +2.24% ▲ 1
39 CRMDCorMedix Inc. Life Sciences 0.19 $576M Neutral +0.60% +2.15% ▲ 1
40 AGIOAGIOS PHARMACEUTICALS, INC. Life Sciences 0.15 $1.8B Neutral +0.67% +2.13% ·
41 ZLABZai Lab Ltd Life Sciences 0.42 $25.3B Neutral +1.32% +2.13% ·
42 ELANElanco Animal Health Inc Life Sciences 0.36 $11.3B Neutral +0.55% +2.05% ▼ 1
43 DBVTDBV Technologies S.A. Life Sciences 0.36 $525M Neutral +0.56% +2.02% ▲ 1
44 KRYSKrystal Biotech, Inc. Life Sciences 0.18 $9.8B Neutral +0.56% +1.98% ·
45 COAGHemab Therapeutics Holdings, Inc. Life Sciences 0.46 $1.4B Neutral +0.54% +1.97% ▼ 1
46 WVEWave Life Sciences, Inc. Life Sciences 0.50 $609M Neutral +0.90% +1.97% ·
47 LKFTLakefront Biotherapeutics NV Life Sciences 0.39 $1.9B Neutral +0.54% +1.95% ▲ 1
48 ARDXARDELYX, INC. Life Sciences 0.38 $795M Neutral +0.52% +1.91% ▼ 1
49 USNAUSANA HEALTH SCIENCES INC Life Sciences 0.59 $282M Neutral +0.73% +1.91% ▲ 1
Since the previous run

Rating changes

▲ 429▼ 601
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-15) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.